Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 15 Dec 2023
Improvements in 2-year PFS and OS, but not for primary refractory illness.
Read Full News1.
Risk of a second cancer after early breast cancer is low, say new findings
2.
Study suggests exercise could reduce breast cancer recurrence
3.
Study recommends new grading system for invasive squamous cell carcinoma of the lung
4.
Distribution of fat could influence cancer risk, study suggests
5.
Algorithm that predicts pancreatic cancer metastasis could help avoid unnecessary surgeries
1.
Uncovering the Mystery of Burkitt's Lymphoma: A New Hope for Treatment
2.
Understanding Hemosiderosis: Causes, Symptoms, and Treatment Options
3.
Fresh Frozen Plasma: Its Role in Treating Trauma and Bleeding Disorders
4.
Cancer Vaccines In India: The Latest Hope In The Fight Against Disease
5.
Polycythemia Vera: A Historical Perspective and Contemporary Management
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Understanding Early Relapse in B-cell ALL: Rates, Risks, and Common Sites
2.
Efficient Management of First line ALK-rearranged NSCLC - Part III
3.
Newer Immunotherapies for Myeloma- A Comprehensive Overview- Part II
4.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion
5.
Navigating the Complexities of Ph Negative ALL - Part V
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge